Exact Mass: 433.3283

Exact Mass Matches: 433.3283

Found 100 metabolites which its exact mass value is equals to given mass value 433.3283, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glycolithocholate

2-[(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]acetic acid

C26H43NO4 (433.3192)


Lithocholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conjugate. is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Lithocholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conjugate. is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

N-Arachidonoyl Glutamic acid

2-[(1-Hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]pentanedioate

C25H39NO5 (433.2828)


N-arachidonoyl glutamic acid, also known as N-arachidonoyl glutamate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Glutamic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Glutamic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Glutamic acid is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Mofarotene

4-(2-{4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]phenoxy}ethyl)morpholine

C29H39NO2 (433.2981)


   

(-)-Korormicin

(-)-Korormicin

C25H39NO5 (433.2828)


   

14-O-Acetylsachaconitine

14-O-Acetylsachaconitine

C25H39NO5 (433.2828)


   

Aspochalasin K

Aspochalasin K

C25H39NO5 (433.2828)


   

11,12-dihydroxy-13-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-1H,2H,3H,4H,6aH,9H,10H,11H,12H,13H,14H,15H,15bH-cycloundeca[e]isoindole-1,15-dione

11,12-dihydroxy-13-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-1H,2H,3H,4H,6aH,9H,10H,11H,12H,13H,14H,15H,15bH-cycloundeca[e]isoindole-1,15-dione

C25H39NO5 (433.2828)


   

lipocarbazole A3

lipocarbazole A3

C30H43NO (433.3344)


   

SCHEMBL6857608

SCHEMBL6857608

C25H39NO5 (433.2828)


   

8-O-acetylkarasamine

8-O-acetylkarasamine

C25H39NO5 (433.2828)


   

spiropachysine-20-one

spiropachysine-20-one

C29H39NO2 (433.2981)


   

Gentamicin VII-3

Gentamicin VII-3

C19H39N5O6 (433.29)


   

ELAIDYLPHOSPHOCHOLINE

ELAIDYLPHOSPHOCHOLINE

C23H48NO4P (433.3321)


   

C25H39NO5_(7E)-11,12-Dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

NCGC00347575-02_C25H39NO5_(7E)-11,12-Dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

C25H39NO5 (433.2828)


   

Glycolithocholic acid

Glycolithocholic acid

C26H43NO4 (433.3192)


CONFIDENCE standard compound; INTERNAL_ID 73

   

N-(3a-Hydroxy-5b-cholan-24-oyl)-glycine

N-(3a-Hydroxy-5b-cholan-24-oyl)-glycine

C26H43NO4 (433.3192)


BA-129-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-129-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

(±)N-(2-fluro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

(±)N-(2-fluro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

C28H48FNO (433.372)


   

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

C28H48FNO (433.372)


   

N-arachidonoyl glutamic acid

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glutamic acid

C25H39NO5 (433.2828)


   

(7E)-11,12-Dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

(7E)-11,12-Dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

C25H39NO5 (433.2828)


   

(+/-)-2,16,16-trimethyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine

(+/-)N-(2-fluoro-ethyl)-2,16,16-trimethyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine

C28H48NOF (433.372)


   

NA 25:6;O4

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glutamic acid

C25H39NO5 (433.2828)


   

NAT 21:0

N-heneicosanoyl taurine

C23H47NO4S (433.3226)


   

stearic acid, compound with 2,2,2-nitrilotriethanol (1:1)

stearic acid, compound with 2,2,2-nitrilotriethanol (1:1)

C24H51NO5 (433.3767)


   

diethyl 2-acetamido-2-[2-(4-octylphenyl)ethyl]propanedioate

diethyl 2-acetamido-2-[2-(4-octylphenyl)ethyl]propanedioate

C25H39NO5 (433.2828)


   

N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide

N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide

C25H39NO5 (433.2828)


   
   

N,N,N-Trihexyl-1-hexanaminium bromide

N,N,N-Trihexyl-1-hexanaminium bromide

C24H52BrN (433.3283)


   

2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid

2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid

C26H43NO4 (433.3192)


   

5,6-Dihydroxy-4-methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

5,6-Dihydroxy-4-methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

C25H39NO5 (433.2828)


   

(25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-26-oate

(25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-26-oate

C27H45O4- (433.3318)


Conjugate base of (25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-26-oic acid.

   

4-[2-[4-[(Z)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]phenoxy]ethyl]morpholine

4-[2-[4-[(Z)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]phenoxy]ethyl]morpholine

C29H39NO2 (433.2981)


   

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]pentanedioic acid

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]pentanedioic acid

C25H39NO5 (433.2828)


   

(9E)-5,6-Dihydroxy-4-methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

(9E)-5,6-Dihydroxy-4-methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

C25H39NO5 (433.2828)


   

3-Nitrobenzyl 3-oxooctadecanoate

3-Nitrobenzyl 3-oxooctadecanoate

C25H39NO5 (433.2828)


   

2-[2,4-bis(4-ethoxyphenyl)-6-methyl-1-pyridin-1-iumyl]-N,N-diethylethanamine

2-[2,4-bis(4-ethoxyphenyl)-6-methyl-1-pyridin-1-iumyl]-N,N-diethylethanamine

C28H37N2O2+ (433.2855)


   

3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoxy]-4-(trimethylazaniumyl)butanoate

3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoxy]-4-(trimethylazaniumyl)butanoate

C27H47NO3 (433.3556)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C24H39N3O4 (433.294)


   

16-hydroxyhexadecanoate 16-O-beta-D-glucoside

16-hydroxyhexadecanoate 16-O-beta-D-glucoside

C22H41O8- (433.2801)


   
   

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]octadeca-9,12,15-trienamide

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]octadeca-9,12,15-trienamide

C27H47NO3 (433.3556)


   

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxynonan-2-yl)octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxynonan-2-yl)octadeca-6,9,12,15-tetraenamide

C27H47NO3 (433.3556)


   

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxyundecan-2-yl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxyundecan-2-yl)hexadeca-4,7,10,13-tetraenamide

C27H47NO3 (433.3556)


   

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]hexadeca-7,10,13-trienamide

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]hexadeca-7,10,13-trienamide

C27H47NO3 (433.3556)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-9-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-9-enamide

C27H47NO3 (433.3556)


   

(E)-2-(decanoylamino)-3-hydroxydodec-4-ene-1-sulfonic acid

(E)-2-(decanoylamino)-3-hydroxydodec-4-ene-1-sulfonic acid

C22H43NO5S (433.2862)


   

(E)-3-hydroxy-2-(undecanoylamino)undec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(undecanoylamino)undec-4-ene-1-sulfonic acid

C22H43NO5S (433.2862)


   

(E)-2-(dodecanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid

(E)-2-(dodecanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid

C22H43NO5S (433.2862)


   

3,5-Di-tert-butyl-N,N-bis(tert-butyldimethylsilyl)aniline

3,5-Di-tert-butyl-N,N-bis(tert-butyldimethylsilyl)aniline

C26H51NSi2 (433.356)


   

(E)-(3R)-(1R,2S,5R)-8-Phenylmenthyl 3-benzylamino-4-hexenoate

(E)-(3R)-(1R,2S,5R)-8-Phenylmenthyl 3-benzylamino-4-hexenoate

C29H39NO2 (433.2981)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]dodec-5-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]dodec-5-enamide

C27H47NO3 (433.3556)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-8-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tridec-8-enamide

C27H47NO3 (433.3556)


   

2-[4-[(3R,5R,8R,9S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[(3R,5R,8R,9S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C26H43NO4 (433.3192)


   

Glycolithocholate

N-[(3alpha,5beta)-3-hydroxy-24-oxocholan-24-yl]-glycine

C26H43NO4 (433.3192)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids The glycine conjugate of lithocholic acid.

   

N-heneicosanoyl taurine

N-heneicosanoyl taurine

C23H47NO4S (433.3226)


   

NA-Cit 18:4(6Z,9Z,12Z,15Z)

NA-Cit 18:4(6Z,9Z,12Z,15Z)

C24H39N3O4 (433.294)


   

NA-DOPA 16:1(9Z)

NA-DOPA 16:1(9Z)

C25H39NO5 (433.2828)


   

NA-Dopamine 19:0

NA-Dopamine 19:0

C27H47NO3 (433.3556)


   

NA-Glu 20:4(5Z,8Z,11Z,14Z)

NA-Glu 20:4(5Z,8Z,11Z,14Z)

C25H39NO5 (433.2828)


   

NA-His 19:1(9Z)

NA-His 19:1(9Z)

C25H43N3O3 (433.3304)


   

NA-Taurine 21:0

NA-Taurine 21:0

C23H47NO4S (433.3226)


   

NA-Thr 22:4(7Z,10Z,13Z,16Z)

NA-Thr 22:4(7Z,10Z,13Z,16Z)

C26H43NO4 (433.3192)


   
   
   

Cer 9:0;O2/18:4

Cer 9:0;O2/18:4

C27H47NO3 (433.3556)


   

ST 23:2;O3;Gly

ST 23:2;O3;Gly

C25H39NO5 (433.2828)


   

ST 24:1;O2;Gly

ST 24:1;O2;Gly

C26H43NO4 (433.3192)


   

(1r,2s,3s,4s,5s,6r,8r,9r,10s,13s,16s,17s)-11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1r,2s,3s,4s,5s,6r,8r,9r,10s,13s,16s,17s)-11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C25H39NO5 (433.2828)


   

1-[(8z)-heptadec-8-en-1-yl]-2-methyl-9h-carbazol-3-ol

1-[(8z)-heptadec-8-en-1-yl]-2-methyl-9h-carbazol-3-ol

C30H43NO (433.3344)


   

methyl (4r)-9-[(1s,3ar,4s,7s,7as)-3,3a-dihydroxy-6,7-dimethyl-1-(2-methylpropyl)-1,4,7,7a-tetrahydroisoindol-4-yl]-4-hydroxy-8-methylnona-2,8-dienoate

methyl (4r)-9-[(1s,3ar,4s,7s,7as)-3,3a-dihydroxy-6,7-dimethyl-1-(2-methylpropyl)-1,4,7,7a-tetrahydroisoindol-4-yl]-4-hydroxy-8-methylnona-2,8-dienoate

C25H39NO5 (433.2828)


   

1-(heptadec-8-en-1-yl)-2-methyl-9h-carbazol-3-ol

1-(heptadec-8-en-1-yl)-2-methyl-9h-carbazol-3-ol

C30H43NO (433.3344)


   

1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C25H39NO5 (433.2828)


   

(3e,5e,7e,10s,11z,13e,15e,17e,20r)-7,15-dimethyl-20-[(2e,4e)-octa-2,4-dien-1-yl]-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,10-diol

(3e,5e,7e,10s,11z,13e,15e,17e,20r)-7,15-dimethyl-20-[(2e,4e)-octa-2,4-dien-1-yl]-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,10-diol

C29H39NO2 (433.2981)


   

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C25H39NO5 (433.2828)


   

methyl 7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

methyl 7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

C25H39NO5 (433.2828)


   

(3r,4z,6e)-n-[(5s)-5-ethyl-5-methyl-2-oxofuran-3-yl]-3-hydroxy-8-[(2s,3r)-3-octyloxiran-2-yl]octa-4,6-dienimidic acid

(3r,4z,6e)-n-[(5s)-5-ethyl-5-methyl-2-oxofuran-3-yl]-3-hydroxy-8-[(2s,3r)-3-octyloxiran-2-yl]octa-4,6-dienimidic acid

C25H39NO5 (433.2828)


   

10-hydroxy-7,15-dimethyl-20-(octa-2,4-dien-1-yl)-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one

10-hydroxy-7,15-dimethyl-20-(octa-2,4-dien-1-yl)-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one

C29H39NO2 (433.2981)


   

11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

11-ethyl-8-hydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C25H39NO5 (433.2828)


   

methyl (1s,4as,4bs,7e,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4as,4bs,7e,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

C25H39NO5 (433.2828)


   

(3s,3ar,4s,6as,11r,12s,13s,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3s,3ar,4s,6as,11r,12s,13s,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C25H39NO5 (433.2828)


   

(3s,3ar,4s,6as,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3s,3ar,4s,6as,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C25H39NO5 (433.2828)


   

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-16-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-16-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

C25H39NO5 (433.2828)


   

11-ethyl-16-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

11-ethyl-16-hydroxy-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate

C25H39NO5 (433.2828)


   

methyl (1s,4as,4bs,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4as,4bs,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

C25H39NO5 (433.2828)


   
   

(4z,6e)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

(4z,6e)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

C25H39NO5 (433.2828)


   

(3s,3ar,4s,6as,11s,12s,13s,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3s,3ar,4s,6as,11s,12s,13s,15ar)-1,11,13-trihydroxy-12-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C25H39NO5 (433.2828)